BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,068 | +2146.7% | 85,400 | +23426.2% | 0.00% | – |
| Q1 2021 | $13,000 | -87.1% | 363 | -81.7% | 0.00% | – |
| Q4 2020 | $101,000 | +288.5% | 1,981 | +263.5% | 0.00% | – |
| Q3 2020 | $26,000 | -40.9% | 545 | -35.5% | 0.00% | – |
| Q2 2020 | $44,000 | – | 845 | +42150.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 2 | -99.8% | 0.00% | – |
| Q4 2019 | $14,000 | -30.0% | 940 | -65.8% | 0.00% | – |
| Q3 2019 | $20,000 | +5.3% | 2,745 | +60.9% | 0.00% | – |
| Q2 2019 | $19,000 | +58.3% | 1,706 | +39.8% | 0.00% | – |
| Q1 2019 | $12,000 | +140.0% | 1,220 | +0.3% | 0.00% | – |
| Q4 2018 | $5,000 | -44.4% | 1,216 | +1.3% | 0.00% | – |
| Q3 2018 | $9,000 | – | 1,200 | +5614.3% | 0.00% | – |
| Q2 2018 | $0 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |